Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.

2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism?

Explore our curated list of biotechnology-themed gifts, ranging from captivating board games to engaging DIY biology kits.

Discover various promising treatments in development to address the unmet needs of people with Charcot–Marie–Tooth disease.

The blueprint used by Kat Arney, chief creative office of First Create the Media

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech landscape.

The FDA approved BridgeBio’s ​​acoramidis in a rare, genetic heart disease that’s expected to become an intense area of market competition, and a broad label will give it a near-immediate boost agains...

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

Researchers say the social-media platform — an alternative to X — offers more control over the content they see and the people they engage with.

Mass delete your Messages, Posts and Comments on over 30+ services.

Delve into the numerous applications of gene therapy, from cancer to hematological disorders and respiratory diseases.

PTC Therapeutics has received FDA approval for a gene therapy to treat AADC deficiency, a rare genetic disorder that impairs the normal function of neurons.

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his latest moves.

/PRNewswire/ -- Freya Biosciences (Freya or the Company), a transatlantic biotech company specializing in women's health, today announces a $10.4 million...